Literature DB >> 19756312

Carbon nanotubes as a protein toxin transporter for selective HER2-positive breast cancer cell destruction.

Xuexiang Weng1, Meiyan Wang, Jing Ge, Shaoning Yu, Baohong Liu, Jiang Zhong, Jilie Kong.   

Abstract

The recombined ricin A chain protein (RTA) was transported into living cells by multiwalled carbon nanotubes (MWNTs) as a cellular carrier, as performed by natural ricin B chain protein (RTB). The conjugate of the toxin protein RTA and MWNT was found to translocate to the cytoplasm of various cell lines and performed biological functions, as evidenced by the induction of cell death. The delivery of RTA into the cells via nanotube carriers was directly visualized by transmission electron microscopy (TEM) and confocal microscopy. About three times higher cell death rates for L-929, HL7702, MCF-7, HeLa and COS-7 cells were demonstrated induced by MWNT-RTA conjugates, compared to those achieved by RTA alone. Especially for HeLa cells, the cell mortality reached approximately 75%. In addition, obvious selective destruction of cancer cells was achieved by coupling MWNTs-RTA-HER2, which selectively recognize the HER2/neu receptor on certain breast cancer cells. This is the first example of recombined protein toxin (RTA)-induced targeting destruction for tumor cells via carbon nanotube molecular transporters. The transporting capabilities of carbon nanotubes combined with functional proteins may open exciting new venues for drug delivery and cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756312     DOI: 10.1039/b906948h

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  10 in total

1.  Advances in Anticancer Protein Delivery Using Micro-/ Nanoparticles.

Authors:  Wujin Sun; Yue Lu; Zhen Gu
Journal:  Part Part Syst Charact       Date:  2014-10-16       Impact factor: 3.310

Review 2.  Eco-friendly synthesis of carbon nanotubes and their cancer theranostic applications.

Authors:  Ebrahim Mostafavi; Siavash Iravani; Rajender S Varma; Mehrdad Khatami; Fatemeh Rahbarizadeh
Journal:  Mater Adv       Date:  2022-05-16

3.  Recent developments in protein and peptide parenteral delivery approaches.

Authors:  Ashaben Patel; Kishore Cholkar; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-03

Review 4.  Potential therapeutic applications of plant toxin-ricin in cancer: challenges and advances.

Authors:  Nikhil Tyagi; Monika Tyagi; Manendra Pachauri; Prahlad C Ghosh
Journal:  Tumour Biol       Date:  2015-09-09

5.  Carbon nanotubes in cancer therapy and drug delivery.

Authors:  Abdelbary M A Elhissi; Waqar Ahmed; Israr Ul Hassan; Vinod R Dhanak; Antony D'Emanuele
Journal:  J Drug Deliv       Date:  2011-10-18

6.  The application of carbon nanotubes in target drug delivery systems for cancer therapies.

Authors:  Wuxu Zhang; Zhenzhong Zhang; Yingge Zhang
Journal:  Nanoscale Res Lett       Date:  2011-10-13       Impact factor: 4.703

7.  Octa-ammonium POSS-conjugated single-walled carbon nanotubes as vehicles for targeted delivery of paclitaxel.

Authors:  Naghmeh Naderi; Seyed Y Madani; Afshin Mosahebi; Alexander M Seifalian
Journal:  Nano Rev       Date:  2015-09-08

8.  PLGA-carbon nanotube conjugates for intercellular delivery of caspase-3 into osteosarcoma cells.

Authors:  Qingsu Cheng; Marc-Olivier Blais; Greg M Harris; Greg Harris; Ehsan Jabbarzadeh
Journal:  PLoS One       Date:  2013-12-03       Impact factor: 3.240

Review 9.  Carbon nanotubes as cancer therapeutic carriers and mediators.

Authors:  Kuk Hui Son; Jeong Hee Hong; Jin Woo Lee
Journal:  Int J Nanomedicine       Date:  2016-10-07

10.  Nanoparticles as Carriers of Proteins, Peptides and Other Therapeutic Molecules.

Authors:  Agnieszka Pudlarz; Janusz Szemraj
Journal:  Open Life Sci       Date:  2018-10-31       Impact factor: 0.938

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.